Huawei Unveils Watch D3 With Advanced Blood Pressure Monitoring in Europe and China

Huawei has been making steady advances in wearable health technology. The company previously released the Watch D2, which was well received for its health monitoring features. In August 2026, Huawei began teasing its next-generation smartwatch, promising significant improvements in blood pressure monitoring.

The Watch D3 was first previewed at a major medical conference in Munich, where Huawei highlighted its ambition to deliver medical-grade accuracy in a consumer device. This early showcase generated curiosity about how the new model would compare to established players like Apple and Google.

On August 31, 2026, Huawei presented the Watch D3 at a medical conference in Munich, showcasing its blood pressure monitoring technology and hinting at an imminent launch, according to Forbes. The device was also previewed at a cardiology congress, where its sleek design and expected price of 449 Euros were revealed, as Digital Trends reported.

By early September, Huawei officially announced the Watch D3 and began marketing it as a major leap in wearable health technology, emphasizing its ability to measure blood pressure during exercise and throughout the day. China-Gadgets noted that the new model is slimmer and offers free access to Huawei Health+ and premium app trials.

The launch event in Munich also marked the start of global sales for several Huawei wearables. 3DNews reported that the Watch D3 was introduced alongside other models at the Olympic Stadium in Munich. The device's standout feature is its inflatable band, which works like a traditional blood pressure cuff, setting it apart from most smartwatches, as Gizmodo Tech explained.

In Poland, the Watch D3 quickly became available for purchase, with local outlets highlighting its pricing and features. Tabletowo described it as a health-focused wearable that promises accurate monitoring without side effects.

The Huawei Watch D3 is now officially available in select markets, including China and Poland. It offers advanced blood pressure monitoring, a luxury design, and promotional offers for early buyers.

Due to ongoing U.S. restrictions, the watch is not expected to launch in the American market. Huawei is targeting consumers interested in premium health tracking, hoping to challenge Apple and Google in the wearables space.

The next steps include seeing how consumers and medical professionals respond to the Watch D3's blood pressure features in real-world use. It will also be important to watch whether Huawei expands availability to more countries or introduces further health monitoring capabilities in future models.